We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
-8.43%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$514M
AUM Growth
-$86.2M
Cap. Flow
-$11.8M
Cap. Flow %
-2.3%
Top 10 Hldgs %
22.06%
Holding
136
New
15
Increased
60
Reduced
35
Closed
13

Top Buys

Rank Stock Value
1
CNMD icon
CONMED
CNMD
+$7.87M
2
GDRX icon
GoodRx Holdings
GDRX
+$6.71M
3
IOVA icon
Iovance Biotherapeutics
IOVA
+$6.43M
4
ACAD icon
Acadia Pharmaceuticals
ACAD
+$5.7M
5
PODD icon
Insulet
PODD
+$5.42M

Top Sells

Rank Stock Value
1
TMCI icon
Treace Medical Concepts
TMCI
+$9.71M
2
INSP icon
Inspire Medical Systems
INSP
+$7.79M
3
AGTI
Agiliti Inc
AGTI
+$7.74M
4
TVTX icon
Travere Therapeutics
TVTX
+$6.69M
5
AMLX icon
Amylyx Pharmaceuticals
AMLX
+$6.63M

Sector Composition

Rank Sector Weight
1 Healthcare 97.41%
2 Industrials 2.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACAD icon
51
Acadia Pharmaceuticals
ACAD
$4.43B
$4.38M 0.85%
+209,960
New +$5.7M
ARWR icon
52
Arrowhead Research
ARWR
$11.9B
$4.23M 0.82%
157,552
+13,630
+9% +$418K
TELA icon
53
TELA Bio
TELA
$32.7M
$4.2M 0.82%
525,000
+346,628
+194% +$3.22M
PTCT icon
54
PTC Therapeutics
PTCT
$5.68B
$4.19M 0.82%
187,016
-44,680
-19% -$1.66M
PGNY icon
55
Progyny
PGNY
$2.44B
$4.08M 0.8%
+120,000
New +$4.53M
SPRY icon
56
ARS Pharmaceuticals
SPRY
$509M
$3.97M 0.77%
1,049,191
-206,449
-16% -$1.36M
RVMD icon
57
Revolution Medicines
RVMD
$39.9B
$3.95M 0.77%
+142,650
New +$4.23M
BIIB icon
58
Biogen
BIIB
$30B
$3.86M 0.75%
15,012
+946
+7% +$253K
IQV icon
59
IQVIA
IQV
$38.7B
$3.74M 0.73%
19,000
-3,100
-14% -$673K
TMO icon
60
Thermo Fisher Scientific
TMO
$213B
$3.63M 0.71%
7,165
– –
HUM icon
61
Humana
HUM
$43.7B
$3.56M 0.69%
7,325
+3,750
+105% +$1.76M
NTLA icon
62
Intellia Therapeutics
NTLA
$1.49B
$3.55M 0.69%
112,332
+11,500
+11% +$446K
CYTK icon
63
Cytokinetics
CYTK
$10.5B
$3.49M 0.68%
118,303
+1,220
+1% +$40.6K
DCGO icon
64
DocGo
DCGO
$64.3M
$3.47M 0.68%
+651,400
New +$5.29M
SWAV
65
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$3.46M 0.67%
17,400
-1,550
-8% -$367K
EW icon
66
Edwards Lifesciences
EW
$49.6B
$3.41M 0.66%
49,200
+13,500
+38% +$1.08M
ATEC icon
67
Alphatec Holdings
ATEC
$1.46B
$3.2M 0.62%
+246,345
New +$3.86M
MDT icon
68
Medtronic
MDT
$109B
$3.14M 0.61%
40,051
– –
IRTC icon
69
iRhythm Holdings
IRTC
$3.85B
$3.11M 0.61%
33,000
+3,000
+10% +$305K
REGN icon
70
Regeneron Pharmaceuticals
REGN
$78.5B
$3.06M 0.6%
3,720
+524
+16% +$412K
VTYX
71
DELISTED
Ventyx Biosciences
VTYX
$3.06M 0.6%
+88,000
New +$3.04M
MDGL icon
72
Madrigal Pharmaceuticals
MDGL
$10.8B
$3.05M 0.59%
20,901
+1,916
+10% +$361K
VRTX icon
73
Vertex Pharmaceuticals
VRTX
$121B
$3.05M 0.59%
8,769
+605
+7% +$212K
OCUL icon
74
Ocular Therapeutix
OCUL
$1.79B
$3.04M 0.59%
969,350
+166,670
+21% +$682K
DXCM icon
75
DexCom
DXCM
$31.5B
$2.96M 0.58%
+31,700
New +$3.57M
1 2
3
4 5

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q3 2023 Portfolio in Review

As of Q3 2023, Sectoral Asset Management held 136 positions worth $514M, down 14% from $600M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Sectoral Asset Management's Q3 2023 filing shows 15 new, 60 increased, 35 reduced and 13 closed positions. Its largest new stake was GoodRx Holdings: 1,007,000 shares worth $5.67M. The largest sale was Treace Medical Concepts, an estimated $9.71M.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 96% a quarter earlier, followed by Industrials.

  • Sectoral Asset Management's largest Q3 2023 buy was GoodRx Holdings: 1,007,000 shares worth $5.67M.
  • Sectoral Asset Management added most to CONMED in Q3 2023, an estimated $7.87M increase.
  • Sectoral Asset Management's biggest Q3 2023 reduction was Amylyx Pharmaceuticals, cutting an estimated $6.63M.
  • Sectoral Asset Management fully exited Treace Medical Concepts in Q3 2023, selling an estimated $9.71M.
  • Sectoral Asset Management's ten largest holdings make up 22% of its $514M portfolio in Q3 2023.
  • Sectoral Asset Management opened 15 new positions and closed 13 in Q3 2023.
  • Sectoral Asset Management's portfolio value fell 14% quarter-over-quarter to $514M.

Based on Sectoral Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.